Supramolecular Polymerization Powered by Escherichia Coli : Fabricating a Near-Infrared Photothermal Antibacterial Agent in Situ

Zihe Yin,Yuchong Yang,Jinpeng Yang,Guobin Song,Hao Hu,Peng Zheng,Jiang-Fei Xu
DOI: https://doi.org/10.31635/ccschem.021.202101490
2021-01-01
CCS Chemistry
Abstract:An Escherichia coli reduction-powered supramolecular polymerization is reported, leading to the fabrication of a near-infrared (NIR) photothermal antibacterial agent in situ. To this end, a bifunctional monomer containing two viologen moieties was designed. When incubating E. coli with the bifunctional monomer and cucurbit[8]uril, viologen moieties were reduced to viologen cation radicals by E. coli, and a supramolecular polymer with supramolecular dimers of viologen cation radicals integrated into the main chain was fabricated on the surface of E. coli. The NIR photothermal conversion property of the supramolecular dimer of viologencation radicals endowed the supramolecular polymer with photothermal antibacterial ability, and this performance was further improved by the local enrichment effect of supramolecular polymers and their enhanced adsorption onto the bacteria surface. Moreover, only certain bacteria, such as E. coli, possess the reducing ability to power supramolecular polymerization, whereas many other bacteria, such as Bacillus subtilis, Pseudomonas aeruginosa, and Staphylococcus aureus, do not possess this ability. Therefore, the supramolecular polymer exhibits outstanding bacterial inhibition efficiency (>99.9%) with high specificity toward E. coli under 1064 nm NIR irradiation. It is anticipated that this biologically powered in situ supramolecular polymerization strategy presents great potential in fabricating smart biomedical supramolecular materials with adaptivity and programmability. [GRAPHICS] .
What problem does this paper attempt to address?